---
configuration: 
  locale: en-US
  dynamo: mock

--- 
- test: CNA_S
- NavigateJoinFilterIntent:
  - request.session.attributes:
      MELVIN.STATE:
        data_type: "CNA"
        data_source: "TCGA"
        study_abbreviation: "OV"
  - response.outputSpeech.ssml: "HCN2 has the greatest number of copy number alterations in Ovarian serous cystadenocarcinoma at 59.5 percent. What else?"
  - response.reprompt.outputSpeech.ssml: "What else?"
  - response.shouldEndSession: false

--- 
- test: CNA_G
- NavigateJoinFilterIntent:
  - request.session.attributes:
      MELVIN.STATE:
        data_type: "CNA"
        data_source: "TCGA"
        gene_name: "TP53"
  - response.outputSpeech.ssml: "For TP53 the greatest number of copy number alterations occur in Sarcoma patients at 37.6 percent. What else?"
  - response.reprompt.outputSpeech.ssml: "What else?"
  - response.shouldEndSession: false

--- 
- test: CNA_GS
- NavigateJoinFilterIntent:
  - request.request.intent.slots:
      query:
        name: "query"
        value: "ovarian cancer"
        confirmationStatus: "NONE"
  - request.session.attributes:
      MELVIN.STATE:
        data_type: "CNA"
        data_source: "TCGA"
        gene_name: "BRCA1"
  - response.outputSpeech.ssml: "In Ovarian serous cystadenocarcinoma patients, Braca one is amplified at 4.5 percent and deleted in 8 percent. What else?"
  - response.reprompt.outputSpeech.ssml: "What else?"
  - response.shouldEndSession: false

--- 
- test: Gain_S
- NavigateJoinFilterIntent:
  - request.session.attributes:
      MELVIN.STATE:
        data_type: "GAIN"
        data_source: "TCGA"
  - request.request.intent.slots:
      query:
        name: "query"
        value: "breast cancer"
        confirmationStatus: "NONE"
  - response.outputSpeech.ssml: "CCND1 has the greatest number of amplifications in Breast invasive carcinoma at 27.4 percent. What else?"
  - response.reprompt.outputSpeech.ssml: "What else?"
  - response.shouldEndSession: false

--- 
- test: Gain_G
- NavigateJoinFilterIntent:
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
        data_type: "GAIN"
        data_source: "TCGA"
  - response.outputSpeech.ssml: "For TP53 the greatest number of amplifications are found in Ovarian serous cystadenocarcinoma patients at 9.4 percent. What else?"
  - response.reprompt.outputSpeech.ssml: "What else?"
  - response.shouldEndSession: false

--- 
- test: Gain_GS
- NavigateJoinFilterIntent:
  - request.request.intent.slots:
      query:
        name: "query"
        value: "breast cancer"
        confirmationStatus: "NONE"
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
        data_type: "GAIN"
        data_source: "TCGA"
  - response.outputSpeech.ssml: "In Breast invasive carcinoma patients, TP53 is amplified at 1.5 percent. What else?"
  - response.reprompt.outputSpeech.ssml: "What else?"
  - response.shouldEndSession: false

--- 
- test: Loss_S
- NavigateJoinFilterIntent:
  - request.session.attributes:
      MELVIN.STATE:
        data_type: "LOSS"
        data_source: "TCGA"
  - request.request.intent.slots:
      query:
        name: "query"
        value: "breast cancer"
        confirmationStatus: "NONE"
  - response.outputSpeech.ssml: "KAZN has the greatest number of deletions in Breast invasive carcinoma at 16.9 percent. What else?"
  - response.reprompt.outputSpeech.ssml: "What else?"
  - response.shouldEndSession: false

--- 
- test: Loss_G
- NavigateJoinFilterIntent:
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
        data_type: "LOSS"
        data_source: "TCGA"
  - response.outputSpeech.ssml: "For TP53 greatest number of deletions are found in Sarcoma patients at 34.1 percent. What else?"
  - response.reprompt.outputSpeech.ssml: "What else?"
  - response.shouldEndSession: false

--- 
- test: Loss_GS
- NavigateJoinFilterIntent:
  - request.request.intent.slots:
      query:
        name: "query"
        value: "breast cancer"
        confirmationStatus: "NONE"
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
        data_type: "LOSS"
        data_source: "TCGA"
  - response.outputSpeech.ssml: "TP53 is deleted in 4.3 percent of Breast invasive carcinoma patients. What else?"
  - response.reprompt.outputSpeech.ssml: "What else?"
  - response.shouldEndSession: false